| Identification | |
| Name: | Benzonitrile,4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]- |
| Synonyms: | R 278474;Rilpivirine; TMC 278 |
| CAS: | 500287-72-9 |
| Molecular Formula: | C22H18 N6 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C22H18N6/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19/h3-9,11-13H,1-2H3,(H2,25,26,27,28)/b4-3+ |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 337.3°C |
| Boiling Point: | 634.1°C at 760 mmHg |
| Density: | 1.27g/cm3 |
| Refractive index: | 1.665 |
| Specification: | N/ABright Yellow Solid usageEng:A novel non-nucleoside reverse transcriptase inhibitor. Rilpivirine seems to be well tolerated with less CNS disturbance than Efavirenz, and has non-teratogenic potential. |
| Flash Point: | 337.3°C |
| Storage Temperature: | Refrigerator |
| Usage: | A novel non-nucleoside reverse transcriptase inhibitor. Rilpivirine seems to be well tolerated with less CNS disturbance than Efavirenz, and has non-teratogenic potential. |
| Safety Data | |
 |
|
